Coronary Heart Disease
While CAC scores may be indicative of CHD, ordering CT scans on young, otherwise healthy individuals may place a burden on the health care system.
For patients with coronary heart disease, mortality is more often due to noncardiovascular causes.
PCKS9 and HMGCR variants were associated with similar protective effects on cardiovascular event risk and diabetes risk.
Postmenopausal women whose weight fluctuated due to dieting had a significantly higher risk for death from sudden cardiac death and coronary heart disease.
A historical analysis shows the Sugar Research Foundation may have influenced a review from Harvard researchers that downplayed the risks of sugar.
Patients with history of gallstone disease may have a slightly increased risk of developing coronary heart disease.
Patients with heterozygous familial hypercholesterolemia have a significantly increased risk for coronary heart disease and atherosclerotic cardiovascular disease.
In light of ELITE trial results, estradiol hormone therapy may have a role in coronary heart disease treatment.
Regularly eating fish and other foods rich in omega-3 fatty acids may lower the risk for fatal coronary heart disease.
The 9-protein risk score performed better than refit Framingham for predicting cardiovascular events.
However, researchers found that the effect waned after nurses stopped working odd hours.
Inclusion of number of vessels with coronary artery calcium significantly improves capacity to predict coronary heart disease and cardiovascular disease.
Intrastudy stabilization and an increase in eGFR was associated with a reduced MACE rate in atorvastatin-treated patients.
Hysterectomy/oophorectomy and earlier age at surgery were associated with increased risk for coronary heart disease.
About 64% of patients aged 80 years or older in the study who died had a prior diagnosis of dementia.
Depressive symptoms seem to be associated with coronary artery calcium in older men and women, according to a study published in The American Journal of Cardiology.
Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.
In a U.K. cohort, association varied with ethnicity and with prediabetes definition criterion.
Additionally, CAC reclassifies patients not eligible for statins.
Initiating hormone therapy earlier in menopause may lower risk for later development of coronary heart disease.
Substituting polyunsaturated fatty acids, carbohydrates from whole grains significantly decreased risk.
Patients saw improvements in cholesterol, blood pressure and weight.
Long-term use of insulin pump reduces fatal coronary heart disease, cardiovascular disease and all-cause mortality.
Trans fats linked to all-cause mortality, total CHD and CHD mortality; and there were no associations for saturated fats.
Older adults with lower scores on executive function tests are significantly more likely to experience coronary heart disease or stroke.
Wide fluctuations between doctor visits tied to higher odds of heart disease and early death.
Clinical and community-based approaches should be used to increase aspirin use among low-use groups.
Increase expected to lead to fewer coronary heart disease events, stroke events and CVD-related deaths.
There are larger differences in nonfatal events seen for whites vs. blacks, but risk for death not affected by race.
Chemotherapy and radiation may damage the heart for decades to come.
Endocrinology Advisor Articles
- ADA Releases Updated Guidelines for Managing Pediatric Type 1 Diabetes
- Relationship Between HbA1c and Coronary Artery Disease
- Intermittent vs Continuous Energy-Restricted Diet: Effects on Glycemic Control and Weight Loss T2D
- The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Self-Administered Contraceptive Vaginal System Approved for Up to 1 Year of Use
- Predictors of Weight Loss in Postpartum Women With Gestational Diabetes
- Genetic Screening May Predict Osteoporosis, Fracture Risk
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- AMA Adopts Policy on Augmented Intelligence